SCHEMBL6538734

SCHEMBL6538734

CCOC(=O)c1ccccc1NC(=O)Nc1ccc(C[C@@H](CO)NC[C@@H](COc2ccccc2)OC(=O)C(F)(F)F)cc1

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ADRB3 P13945 12/20 0.54
ADRB1 P08588 10/20 0.54
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA9 Q16790 1/20 0.44
TSHR P16473 2/20 0.42
MAPK10 P53779 1/20 0.42
KDM4E B2RXH2 2/20 0.42
MEN1 O00255 1/20 0.42
PKM P14618 1/20 0.42
KMT2A Q03164 1/20 0.42
TDP1 Q9NUW8 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
ALDH1A1 P00352 2/20 0.41
MAPK1 P28482 1/20 0.41
PPIA P62937 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.38
HPGD P15428 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6539488 0.92 ADRB3 (0.57) ADRB3ADRB1MEN1KMT2ASMN1; SMN2
Trifluoroacetic Acid SCHEMBL6538740 0.89 ADRB3 (0.68) ADRB3ADRB1CA12CA1CA2
SCHEMBL6539241 0.87 ADRB3 (0.60) ADRB3ADRB1CA12CA1CA2
SCHEMBL6539720 0.87 ADRB3 (0.60) ADRB3ADRB1KDM4EMEN1PKM
SCHEMBL6539718 0.85 ADRB3 (0.61) ADRB3ADRB1SMN1; SMN2HPGD
SCHEMBL6538790 0.85 ADRB3 (0.56) ADRB3ADRB1KDM4EMEN1KMT2A
SCHEMBL7532289 0.83 ADRB3 (0.58) ADRB3ADRB1
SCHEMBL6541344 0.83 ADRB3 (0.58) ADRB3ADRB1MEN1KMT2A
SCHEMBL6539506 0.82 ADRB3 (0.59) ADRB3ADRB1
SCHEMBL7533764 0.82 ADRB3 (0.58) ADRB3ADRB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6826033-B2 BETA 3 ADRENERGIC RECEPTOR AGONISTS; TREATMENT OF POLLAKIURIA, URINARY INCONTINENCE, OBESITY OR DIABETES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-11-30 US disclosed
WO-2002024635-A2 AMINOALCOHOL DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-03-28 WO disclosed